LauraJustineTafeMD

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology, Geisel School of Medicine

Dr. Tafe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Wayne State University School of MedicineClass of 2004

CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth Start of enrollment: 2024 Mar 19
Recruiting
Not Applicable
Roles: Principal Investigator, Contact

PubMed

282 citations
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
Yelena Y. Janjigian, D. Werner, Claudia Pauligk, K. Steinmetz, David P. Kelsen
Annals of Oncology. 2012-10-01
80 citations
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma.
Anna Biernacka, Peter D. Tsongalis, Jason D. Peterson, Francine B. de Abreu, Candice C. Black
Cancer Genetics. 2016-05-01
20 citations
Non–small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
Laura N. Toth, Francine B. de Abreu, Laura J. Tafe
Human Pathology. 2018-08-01

Dartmouth-Hitchcock Pathologist Laura Tafe, MD, Elected President of the Association for Molecular PathologyJuly 15th, 2021
Dartmouth Investigators Study Impact of Shift in Testing Guidelines for Assessing HER2 Status in Breast Cancer PatientsFebruary 12th, 2016
Could Creativity Transform Medicine? These Artists Think SoNovember 13th, 2023